期刊文献+

醛固酮与组织纤溶酶原激活物抑制物-1水平对急性冠脉综合征患者冠脉病变及近期预后的预测价值

The predictive value of Aldosterone and PAI-1 to the severity of coronary artery lesions and recent prognosis in patients with Acute coronary syndrome
原文传递
导出
摘要 目的 分析急性冠脉综合征(ACS)患者血浆醛固酮、纤溶酶原激活物抑制物1(PAI-1)水平对冠状动脉病变严重程度及患者近期预后的影响,并探讨两者的相关性.方法 选择行冠脉造影检查的患者160例,分为对照组(非冠心病组)48例和ACS组112例.冠脉造影检查前于升主动脉根部采血标本,测定醛固酮、PAI-1水平,根据冠脉造影结果,分析其与冠脉病变严重程度的关系;按冠脉病变狭窄程度积分(Gensini 积分)将入选病例分为低、中、高分三组,观察Gensini积分高低与血浆醛固酮、PAI-1水平的关系,并分析醛固酮、PAI-1对ACS患者经皮腔冠脉内介入治疗(PCI)后近期预后的预测价值.结果 (1)ACS组患者血浆醛固酮、PAI-1水平明显高于对照组患者(均P〈0.05).(2)随Gensini积分升高,患者血浆醛固酮、PAI-1水平亦明显升高,三组患者血浆醛固酮、PAI-1水平:高分组〉中等组〉低分组(均P〈0.05).(3)ACS组患者血浆醛固酮与PAI-1呈显著性正相关(r=0.213,P〈0.05).(4)多因素Logistic回归分析显示醛固酮、PAI-1是ACS患者PCI术后30 d内MACE发生的独立预测因子.结论 ACS患者血浆醛固酮、PAI-1水平与冠脉病变严重程度相关,醛固酮与PAI-1之间的相互影响,并对ACS患者PCI术后的近期预后有预测价值. Objective To investigate the predictive value of serum aldosterone and Plasminogen activator inhibitor-1 ( PAI-1 ) levels to the severity of coronary artery lesions and the recent prognosis in acute coronary syndrome (ACS) patients underwent percutaneous coronary intervention(PCI). Methods The study included 160 consecutive patients admitted. All the patients received coronary angiography and were divided into two groups:control group and ACS group. The patients' blood samples were abtained at the root of aortic artery to measure the serum aldosterone and PAI-1 levels. We analyzed their relationship with the severity of coronary artery lesions. The patients were also divided into three groups( high-score group, moderate-score group,low-score group)according to Gensini accumulated points,we analyzed the difference of aldosterone and PAI-1 levels in three groups. The predictive values of aldosterone and PAI-1 to the recent pronosis of ACS patients underwent PCIwere assessed. Results ( 1 )The patients' serum aldosteeone and PAI-1 levels in ACS group were significantly higher than control group( all P 〈0. 05 ) ;(2)The aldosterone and PAI-1 levels in high-score group were higher than moderate-score group, and moderate-score group was higher than low-score group. (3)The serum aldosterone level in ACS patients was positively correlated with the PAI-1 level ( r = 0.213, all P 〈 0. 05 ). ( 4 ) Multiple factor Logistic regression analysis indicated that aldosterone, PAI-1 levels were srtong independent predictors for the recent prognosis of ACS patients underwent PCI. Conclusion The aldosterone ,PAI-1 levels in ACS patients were correlated with the severity of coronary artery lesions. Both of them were strong predictors for the recent prognosis of ACS patients underwent PCI.
出处 《中国基层医药》 CAS 2010年第19期2619-2621,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 醛固酮 组织纤溶酶原激活物抑制物-1 急性冠脉综合征 血管成形术 经腔 经皮冠状动脉 Aldosterone Plasminogen activator inhibitor-1 ( PAI-1 ) Acute coronary syndrome,angioplasty,transluminal ,percutaneous coronary
  • 相关文献

参考文献9

  • 1Pitt B,White H,Nicolau J,et al.Eplerenone reduces mortality 30days ater randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.J Am Coil Cardiol,2005,46 (3):425-431.
  • 2Folsom AR,Aleksic N,Park E,et al.Prospective study of fibrinolytic factors and incident coronary heart disease:the Atherocclerosis Risk In Communities(ARIC) Study.Arterioscler Thromb Vasc Biol,2001,21 (4):611-617.
  • 3吕树铮.2007年冠心病研究回顾[J].中国心血管病研究,2008,6(4):241-243. 被引量:31
  • 4Katayama T,Nakashima H,Furudono S,et al.Evaluation of neurohumoral activation (adrenomedullin,BNP,Caecholamines,etc.)in patients with acute myocardial infarction.Intern Med,2004,43(11):1015-1022.
  • 5田洪森,丁文惠.肾素-血管紧张素系统与纤溶功能[J].国外医学(生理病理科学与临床分册),2000,20(1):8-11. 被引量:5
  • 6Vaughan DE,Lazos SA,Tong K.Angiotensin Ⅱ regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells.J Clin Invest,1995,95 (3):995-1001.
  • 7Brown NJ,Kim KS,Chen YQ,et al.Synergistic effects of adrenal steroids and angiotensin Ⅱ on plasminogen activator inhibitor-1 production.J Clin Endocrinol Metab,2000,85 (1):336-344.
  • 8袁军,贾汝汉,包艳,丁国华.活性氧和转化生长因子β1在醛固酮上调纤溶酶原激活物抑制剂1中的作用[J].中华肾脏病杂志,2006,22(12):758-762. 被引量:8
  • 9Beygui F,Collet JP,Benoliel JJ,et al.High plasma aldostrone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction.Circulation,2006,114(24):2604-2610.

二级参考文献27

  • 1姜宗培,余学清,陈雄辉,杨念生,河宪珠,李熙渤.转化生长因子β1对系膜细胞纤溶酶原激活物抑制物1表达的影响[J].中华肾脏病杂志,2004,20(4):260-263. 被引量:11
  • 2Browa NJ, Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens,2005,14:235-241.
  • 3Epstein M. Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives. Intern Med,2001,40:573-583.
  • 4Ha H, Lee HB. Beactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol,2003,14(8 Suppl 3):S246-S249.
  • 5Lee HB, Yu MB. Yang Y, et al. Reactive oxygen speciesregulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol, 2003,14(8 Suppl 3):S241-S245.
  • 6Kagami S, Kuhara T, Okada K, et al. Dual effects of angiotensin Ⅱ on the plasminogen/plasmin system in rat mesangial cells. Kidney Int, 1997,51:664-671.
  • 7Hagiwara H, Kaizu K, Uriu K, et al. Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models. Thromb Res, 2003, 111:301-309.
  • 8Eddy AA. Plasminogen activator inhibitor-1 and the kidney.Am J Physiol Renal Physiol, 2002, 283 :F209-F220.
  • 9Ma J, Weisberg A, Griffin JP, et al. Plasminogen activator inhibitor- 1 deficiency protects against aldosterone-induced glomerular injury. Kidney Int, 2006, 69:1064-1072.
  • 10Rerolle JP, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int, 2000, 58:1841-1850.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部